Chengdu Xilingyuan Pharmaceutical Co., Ltd.

Chengdu Xilingyuan Pharmaceutical Co., Ltd. (hereinafter referred to as Xilingyuan Pharmaceutical) is a cutting-edge pharmaceutical R&D company based in China and operating globally, which develops "globally new" innovative drugs and high-barrier generic drugs with catalytic synthesis technology as its anchor. The company has successfully built three major technology platforms: innovative conjugated drugs, high-end generic drugs, and characteristic catalytic technology, forming a full industry chain development layout of drug R&D, clinical research, industrialization (MAH) and commercialization (cooperation).